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Abstract
Newcastle Disease Virus (NDV) is a pathogenic strain of avian paramyxovirus (aPMV-1) that is among the most serious of
disease threats to the poultry industry worldwide. Viral diversity is high in aPMV-1; eight genotypes are recognized based on
phylogenetic reconstruction of gene sequences. Modified live vaccines have been developed to decrease the economic
losses caused by this virus. Vaccines derived from avirulent genotype II strains were developed in the 1950s and are in use
globally, whereas Australian strains belonging to genotype I were developed as vaccines in the 1970s and are used mainly
in Asia. In this study, we evaluated the consequences of attenuated live virus vaccination on the evolution of aPMV-1
genotypes. There was phylogenetic incongruence among trees based on individual genes and complete coding region of
54 full length aPMV-1 genomes, suggesting that recombinant sequences were present in the data set. Subsequently, five
recombinant genomes were identified, four of which contained sequences from either genotype I or II. The population
history of vaccine-related genotype II strains was distinct from other aPMV-1 genotypes; genotype II emerged in the late
19
th century and is evolving more slowly than other genotypes, which emerged in the 1960s. Despite vaccination efforts,
genotype II viruses have experienced constant population growth to the present. In contrast, other contemporary
genotypes showed population declines in the late 1990s. Additionally, genotype I and II viruses, which are circulating in the
presence of homotypic vaccine pressure, have unique selection profiles compared to nonvaccine-related strains.
Collectively, these data show that vaccination with live attenuated viruses has changed the evolution of aPMV-1 by
maintaining a large effective population size of a vaccine-related genotype, allowing for coinfection and recombination of
vaccine and wild type strains, and by applying unique selective pressures on viral glycoproteins.
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Introduction
Live attenuated virus vaccines have been successfully employed
in veterinary medicine to prevent the economic impact of many
diseases in poultry and livestock. However, the role of vaccination
with attenuated viruses on the evolution of wild type strains is not
often considered. Antigenic escape because of strong selection by
vaccines, emergence of new strains through recombination, and
increased virulence to expedite transmission of new genotypes in
vaccinated populations are of potential concern. In this paper, we
explored the consequences of vaccination on the evolution of class
II aPMV-1, which is the etiological agent of ND.
NDV, a single-stranded, non-segmented, negative-sense RNA
virus of the genus Avulavirus, family Paramyxoviridae, infects a
wide range of domestic and wild bird species worldwide, and
causes a significant economic burden to the poultry industry [1].
The first outbreaks of NDV were reported during the mid 1920s in
Java, Indonesia and Newcastle-upon-Tyne, England [2], and
within a few years were occurring throughout the world [3]. The
name ND is reserved exclusively for the disease that results from
infection with strains of aPMV-1 that are pathogenic for domestic
chickens [4]. aPMV-1 has been grouped by virulence phenotype,
with lentogenic, mesogenic, and velogenic strains representing
increasing levels of virulence, ranging from subclinical infections
with moderate respiratory involvement to extensive hemorrhagic
lesions and neurological signs [5]. Inactivated vaccines were first
made commercially available to the poultry industry in 1946, but
because they provided incomplete protection against ND [6], they
were replaced with live lentogenic NDV vaccines. Although these
vaccines reduce disease, they do not always prevent infection and
birds can shed both vaccine and challenge strains of the virus
[7,8,9].
aPMV-1 genome size is approximately 15 kb and encodes six
genes, which produce nucleocapsid protein (NP), phosphoprotein
(P), matrix protein (M), fusion protein (F), hemagglutinin-
neuraminidase (HN), and polymerase protein (L) [10,11]. RNA-
editing of P gene creates two additional proteins, V and W [12].
There are nine serotypes of aPMV-1; viruses associated with ND
are in serogroup 1. Within serogroup 1 there are 2 major
subdivisions, class I and II, based on phylogenetic grouping of the
F gene [13]. Class I aPMV-1 are primarily recovered from
waterfowl or samples from U.S. live bird markets, while the
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avian species [5,14]. Eight genotypes of class II aPMV-1 can be
identified [13]. Viruses belonging to genotypes I-IV have
circulated since the 1930’s. Genotype I and II consist of both
lentogenic and velogenic viruses and have been associated with
ND outbreaks in Australia and North America, respectively
[5,15,16]. These viruses have been attenuated in culture and are
used as modified live vaccines [16]. Genotypes V-VIII were first
recognized in the mid-1960s [13] and contained only virulent
viruses [16]. Genotype V was responsible for the second panzootic
of ND in Europe from 1970–1974 and has been detected
sporadically thereafter [17]. Genotype VI was described mainly
from the Middle East and Asia during the 1980’s–1990’s [18] and
genotype VII and VIII were reported in the 1990’s from several
countries [19,20,21,22,23,24]. All genotypes, except IV [16], are
still in circulation.
RNA viruses typically have a high mutation rate due to low
fidelity and processivity of their polymerase [25], which coupled
with a high replication rate and short generation time [26] lead to
high evolutionary rates. In addition, evidence is accumulating that
recombination is an important process driving genotype diversity
for many RNA viruses [27,28,29]. Although recombination was
not thought to contribute to aPMV-1 evolution [30,31], evidence
of recombination in NDV has recently been reported [32,33,34].
This debate may be due, in part, to the reliance on a single gene
for determining virus diversity and phylogeny. Because recombi-
nation can lead to the emergence of novel virus strains of unknown
virulence [35,36,37,38], a better understanding of the role of
recombination in circulating aPMV-1 is warranted.
In this study, we explored how vaccination strategies in poultry
farming have shaped the evolution of this important avian virus
using complete genome sequences available in GenBank. Specif-
ically our objectives were to 1) determine if recombination was
evident among full length class II aPMV-1; 2) estimate
evolutionary rates of each genotype; 3) estimate the effective
population size of each genotype; and 4) determine the selective
forces on vaccine-related and nonvaccine-related wild type
genotypes. Our results confirm that recombination is an important
process in this negative sense RNA virus and that vaccine-related
strains have an evolutionary history that is unique from
nonvaccine-related strains, which includes distinct evolutionary
rates, temporal changes in population size, and selection profiles.
Results
Phylogenomic analyses
The current phylogenetic classification of aPMV-1 strains is
based on either full or partial nucleotide sequence of the M, F, or
L genes. To determine if all genes in the viral genome provided
consistent phylogenetic profiles, we obtained 54 full length class II
aPMV-1 sequences from Genbank and generated nucleotide data
sets for each of the six genes and a concatenated sequence of all
protein coding regions. Maximum likelihood (ML) phylogenies
were reconstructed for all sequence data sets under the
appropriate nucleotide substitution model selected for each data
set (Figure 1). Each gene tree and the concatenated tree revealed
seven distinct genotypes within the class II aPMV-1. However,
genotype affiliations were not congruent among different genes
(Figure 1A). While genotype III, IV, V, VI, and VII were
monophyletic, genotype I and II showed inconsistent phylogenetic
relationships (Figure 1A and B). Three distinct patterns of
affiliations of genotype I and II were observed among different
gene trees. The NP, HN, L, and concatenated gene trees
consistently placed genotypes I and II in a sister clade to other
genotypes. In the P gene tree, genotype II formed a basal clade
while genotype I clustered with the remaining genotypes and in
the M and F gene trees, genotype I was the basal clade and
genotype II clustered with the remaining genotypes.
Several taxa changed genotype affiliations in different gene trees
and all discordant taxa were affiliated with vaccine-related
genotype II in some gene trees (Figure 1C). For example, isolate
AY562985 (Cockatoo/14698/Indonesia/1990) was affiliated with
genotype II in the NP gene tree but with genotype VII in all other
gene trees. This isolate occupied a long branch in the genotype VII
sequences in the P gene tree. Isolate AY562989 (Dove/2736/
Italy/2000) was affiliated with genotype II in the M gene tree but
with genotype VI in all remaining trees except the P gene, in
which it was an outlier to all other genotypes. Isolate AY225110
(HB92 isolate V4 vaccine/China) affiliated with genotype I in M
and L gene trees but with genotype II in other gene trees. Isolate
EU167540 (Layer/SRZ03/China/2003) affiliated with genotype
VII in all gene trees but it occupied a long branch in genotype II in
F gene tree. A Shimodaira-Hasegawa test (SH-test) provided
statistical support of taxon incongruence (p,0.005) among the
gene trees (data not shown). Phylogenetic incongruence among
genes suggests that recombination might play a role in class II
aPMV-1 diversity.
Detection of recombinant viruses
To further investigate the possibility of recombination among
the full length aPMV-1 sequences, we used seven different
algorithms implemented in the RDP3 program [39,40]. Chimeric
NDV vaccine strain EU140955, which has the genotype II La
Sota vaccine strain backbone and the F and HN genes from a
contemporary genotype VII virus (Figure 1C), was included as a
control to evaluate the prediction capability of the program. The
predicted recombination breakpoint (detected by five methods
with p-value,10
25) at position 7119 of the concatenated
EU140955 matched correctly with the end of a SpeI restriction
site of this chimeric strain where HN sequences were inserted from
the KBNP-4152 strain. The MluI restriction site used to generate
the chimera is within the intergenic region between M and F genes
Author Summary
Modified live virus (MLV) vaccines have been effective in
reducing disease burden and economic loss caused by
Newcastle Disease (ND) in domestic poultry. Because the
vaccine is a live virus, it is transmissible among birds. Thus,
vaccination strategies have the potential to impact the
evolutionary genetics of wild type strains of aPMV-1
including those that cause ND. In this report, we provided
evidence that viruses isolated from wild and domestic
birds have recombined with vaccine strains, because
vaccinated birds are protected from disease but not
infection with other strains of aPMV-1. Despite the use of
vaccines since the 1950s, the population size of the strain
from which the most widely used vaccine was derived has
steadily increased. In contrast, other contemporary geno-
types, which emerged in the 1960s, experienced a decline
in population size in 1998, which may reflect a change in
poultry farming practices or disease. Vaccination imposed
a unique selection profile on the genotypes derived from
the vaccine-related strains when compared with nonvac-
cine-related strains. Although modified live viruses are
important for controlling Newcastle Disease, the potential
of vaccination strategies to change viral diversity and
population dynamics should be considered.
Vaccination and Viral Evolution
PLoS Pathogens | www.plospathogens.org 2 April 2010 | Volume 6 | Issue 4 | e1000872Figure 1. Maximum likelihood trees showing phylogenetic relationships among different genotypes. A total of 54 isolates representing
seven different genotypes were used in the phylogenetic reconstruction. (A) Genotype topology based on each of the six aPMV-1 genes. Area of the
triangle is proportional to the number of isolates within the genotype. (B) ML tree inferred from the concatenated gene sequences of the 54 isolates.
Genbank accession number is shown for each isolate. Bootstrap supports are given at the base of the nodes. All trees are rooted with strain
DQ097393, which belongs to class I aPMV-1. The trees are midpoint rooted for clarity. (C) Diagram of genotype affiliation of each gene for isolates
that showed topological incongruence in different gene trees. Genotypes I, II, III, IV, V, VI, and VII, are coded with red, yellow, lime-green, dark-green,
purple, cyan, and blue colors, respectively.
doi:10.1371/journal.ppat.1000872.g001
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reasonably identified the 59 breakpoint at the 8th nucleotide of the
F-gene. Two additional recombination breakpoints within this
insert were also detected by the GENECONV and Bootscan
methods (p-value 2.29610
23 and 3.35610
22). These correspond-
ed to the positions in the F gene segment of KBNP-4152 strain
that were mutagenized to attenuate recombinant strain
EU140955. Thus, we conclude that the RDP3 program accurately
identifies recombination if five or more methods have statistical
support of p#10
25 for the breakpoints and we propose that any
breakpoints statistically supported with only one or two methods
should be carefully interpreted.
Using the stringent criteria defined above, a total of five putative
recombinant isolates were detected (Figure 2). Four of these
isolates, AY562985, EU167540, AY562989, AY225110, were
those that showed discordant phylogenies described above
(Figure 1C), and in each case, some recombinant regions were
derived from genotype II sequences. Isolate AY562985 is
predominantly genotype VII and had evidence of two recombi-
nation events based on RDP3 predictions. We confirmed that
regions 508 to 926 (in NP) and 927 to 1511 (NP and P) are related
to genotypes V and II, respectively by partitioning the data sets at
the predicted break points and reconstructing a ML phylogeny
(Figure 3). In the region 927 to 1511, AY562985 had seven unique
synonymous substitution sites compared to the other sixteen
genotype II sequences in our dataset. Isolate AY562989, which is
predominantly of genotype VI origin, also contained a putative
recombinant region spanning positions 2039 to 3225, which was
derived from genotype II and had three unique non-synonymous
substitution sites compared to other genotype II sequences. Isolate
AY225110 is a chimera of genotype I and II sequences. Compared
to genotype II sequences, there were seven unique sites, four of
which were non-synonymous substitutions, from the 59 end of NP
to position 2702; two synonymous and two non-synonymous
substitution sites in the 3757–7149 fragment; and two synonymous
and seven non-synonymous substitution sites within the region
Figure 2. Recombination breakpoint map of eleven isolates detected by different methods implemented in RDP3 program. The
nucleotide position of breakpoints in the concatenated genome is indicated. Regions that correspond to different genotypes are shown using the
color scheme described in Figure 1. Superscripts a and b indicate statistical support (p-value#10
25) from 5 or 3–4 methods, respectively. Superscripts
c and d indicate statistical support (p-value#10
23) from 2 to 4 or 1 method, respectively. Asterisk indicates that breakpoints could not be identified.
Genes are not drawn to scale.
doi:10.1371/journal.ppat.1000872.g002
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recombination region between position 3753 and 4345 was
affiliated with genotype II and had one non-synonymous
substitution site compared to other strains. Thus, genotype II,
which is used in vaccines globally, has recombined with at least
three other class II aPMV-1 strains and the recombinant viruses
have been isolated from both domestic and wild birds.
The fifth virus identified by all RDP3 methods, DQ485230, was
a genotype VII isolate that contained a small region within the HN
gene contributed by genotype III. In addition, a region spanning
1479 to 3751 in P and M appeared to be derived from a different
genotype VII virus. Inter-genotype recombination was also
detected by fewer than five of the RDP3 methods in
DQ486859(GM/China), DQ485231(Guangxi11/China/2003)
and AF309418(Fowl/B1/USA/1947). Genotype VII isolate
DQ659677(NA-1/China) contained a 640 bp region within L
contributed from genotype VI. The origin of the putative
recombinant fragment spanning the M and F genes of
EF065682(rAnhinga/USA) could not be determined. These data
provide compelling evidence that genotypes II and VII are most
commonly associated with recombinant viruses and that both
intra- and intergenic recombination events can be detected using
full genome sequence analysis.
Phylogenomic analyses without recombinant sequences
Phylogenies of individual and concatenated genes were
reconstructed after the removal of the five putative recombinant
isolates and chimeric vaccine strain EU140955 (Figure 4).
Consistent with Figure 1A and 1B, genotypes III - VII clustered
together as a monophyletic group in all trees. All taxa were
consistently affiliated with a single genotype and there were no
long branches associated with any genotype. Two of the three
original patterns of phylogenetic affiliation were retained following
removal of recombinant sequences. The placement of genotypes
based on HN and L was the same with or without recombinants;
genotype I and II were sister groups to genotype III, IV, V, VI,
and VII (Figure 1A; Figure 4). All of the remaining trees presented
a topology similar to that of the P gene-tree before recombinant
removal, which placed genotype I with III-VII. It is noteworthy
that in the absence of recombinant sequences, genotype II is never
clustered with genotypes III-VII, as was seen with trees based on
M and F in the presence of recombinant sequences (Figure 1A).
Evolutionary rates and population dynamics
We inferred the evolutionary rates and past population
dynamics of class II aPMV-1 using a Bayesian coalescent
approach [41]. This analysis was based on all full length genome
sequences in the data set which had a date of isolation and
excluded the six recombinant sequences. Bayesian estimates of
the evolutionary rates of each gene and concatenated coding
genome of class II aPMV-1 were between 0.98610
23–
1.56610
23 substitutions/site/year (Table 1). Evolutionary rate
estimates under a relaxed clock with HKY+G4 (Table S4) and
GTR+G6 (Table 1) substitution models were consistent. The
time to the most recent common ancestor (TMRCA) of class II
aPMV-1 was estimated to be between 114 and 137 years before
2005, or between year 1868 and 1891. Bayesian skyline plots
(BSP) were used to infer how effective population size has
changed with time [41,42]. All six protein-coding genes and the
concatenated genome maintained constant effective population
size until the late 1990’s (Figure 5A). In 1997-8 there was an
abrupt decline in the population with recovery from this event
in the early 2000.
To determine if all genotypes exhibited the same population
history observed for the composite genotype data set, we repeated
the analysis based on 97 dated full length F genes, which provided
a larger data set for this analysis. Isolates from genotype III, IV,
and V were not included because limited numbers of dated
sequences were available. The TMRCA for genotype II was
estimated to be 1899620 years, and the estimated evolutionary
rates were between 0.3–1.1610
24 substitutions/site/year, making
this the slowest evolving aPMV-1 genotype (Table 2). Genotype I
Figure 3. ML trees on the three putative recombinant regions identified in AY562985. A–C represent the phylogenies of regions spanning
nucleotide position 508–926, 927–1511, and 1512–2671, respectively. The position of AY562985 is highlighted in each tree. Genotypes I, II, III, V, VI,
and VII are coded using the color scheme described in Figure 1. Trees are rooted with strain DQ097393, which belongs to class I aPMV-1.
doi:10.1371/journal.ppat.1000872.g003
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rates than genotype II. The most recently emerged strain was
genotype VII, which dates to the late 1970’s and had the highest
evolutionary rate. BSP analyses based on the F gene demonstrated
that each genotype had a unique population history. Prior to the
emergence of genotype VII in the 1970s (phase i), genotype II
showed an increase in population size (Figure 5B). After the
emergence of genotype VII (phase ii) the population size of
genotype VI began to increase, while that of genotypes I and VII
were relatively constant. Phase iii depicts the time of the
population bottleneck observed in Figure 5A, which was based
on all genes in the composite genotype data set. Only genotypes I
and VI show a trend for decreasing population size during this
time. The last decade has been the most dynamical for the four
genotypes of aPMV-1 (phase iv; Figure 5B). Genotypes I and VII
showed a marginal increase in effective population size followed by
a decline; genotype I has continued to decline, whereas genotype
VII appears to have stabilized. Genotype VI showed continuous
Figure 4. Phylogenetic relationships among 48 non-recombinant isolates. A maximum likelihood tree was produced after removal of the six
putative recombinant sequences. The color scheme, rooting, and bootstrap values are as described in Figure 1.
doi:10.1371/journal.ppat.1000872.g004
Table 1. Bayesian estimates of evolutionary rates (nucleotide substitutions per site per year) and TMRCAs (in year) for different
genes of class II PMV-1.
Gene Evolutionary rate (610
23 sub/site/yr) TMRCA in year (95% HPD)
NP 0.98 (0.45–1.50) 1868 (1713–1927)
P 1.56 (0.78–2.32) 1884 (1750–1931)
M 1.17 (0.54–1.76) 1872 (1737–1931)
F 1.35 (0.71–1.98) 1891 (1777–1931)
HN 1.10 (0.51–1.68) 1869 (1719–1928)
L 1.02 (0.59–1.44) 1878 (1764–1924)
Concatenate 1.19 (0.50–1.74) 1885 (1731–1929)
Estimates are based on the relaxed clock with uncorrelated exponential distribution (UCED).
doi:10.1371/journal.ppat.1000872.t001
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estimates of population sizes for genotypes I, VI, and VII, have
some degree of overlaps at the 95% posterior limit, genotype II
shows no sign of reduction in effective population size since its
origin (Figure 5B).
Selection profiles
We compared the selection profiles on protein coding genes of
genotypes I and II, which include strains that are circulating in the
face of homotypic vaccination pressure (designated as the vaccine-
related group), and genotypes III-VII (designated as the non-
vaccine-related strains) (Table 3). Overall, the global rate of non-
synonymous to synonymous substitutions (dN/dS) for all protein
coding genes were less than 1, indicating purifying selection has
been the major driving force in the evolution of class II aPMV-1
viruses. There were no codons identified to be under positive
selection in M and L genes in either group (Table 3). However,
there was a clear difference in the codon based selection profiles of
N, P, F and HN genes between the vaccine- and nonvaccine-
related groups. In the vaccine-related group, only the surface
protein encoding genes, F and HN, had positively selected codons.
Both groups had a single site identified in F; these were at codon
115 within the F0 cleavage site for the vaccine-related group and
codon 28 in the signal peptide for the nonvaccine-related group.
There were 3 positively selected sites identified in the HN gene in
the vaccine-related group and one in the non vaccine-related
group. In contrast, the P gene of nonvaccine-related genotypes III-
VII had three sites predicted to be under positive selection but no
sites were identified in the vaccine-related group. Thus, selection is
focused on HN in vaccine-related groups and on P in nonvaccine-
Figure 5. Bayesian skyline plots (BSP) depicting effective population size of class II aPMV-1 over time. Effective population size
estimates are expressed on a logarithmic scale (y axis). Solid lines denote the median estimates and the dotted lines give the 95% HPD intervals of the
estimates. The shaded light blue region indicates a population bottleneck. BSP based on (A) individual genes and concatenated genome sequences.
The figure highlights the interval from 1965–2005; the entire estimate is displayed in the inset. The dark blue, red, pink, blue, light green, light blue
and green lines are the estimates based on the concatenated sequence, NP, P, M, F, HN and L genes, respectively; (B) individual genotypes (I, II, VI,
and VII) using complete F gene sequence. Symbols i-iv represent four phases of aPMV-1 history (described in detail in text). Genotype I, II, VI and VII,
are coded by red, yellow, dark blue, and light blue lines, respectively.
doi:10.1371/journal.ppat.1000872.g005
Table 2. Bayesian estimates of evolutionary rates (nucleotide substitutions per site per year) and TMRCAs (in year) based on the
complete F gene of class II PMV-1 genotypes.
Genotype Evolutionary rate (610
-3 sub/site/yr) TMRCA in year (95% HPD)
I 1.73 (0.59–2.82) 1964 (1928–1969)
II 0.06 (0.03–0.11) 1899 (1888–1919)
VI 1.80 (0.85–2.69) 1963 (1915–1974)
VII 2.89 (1.27–4.43) 1978 (1940–1989)
Estimates are based on the relaxed clock with uncorrelated exponential distribution (UCED).
doi:10.1371/journal.ppat.1000872.t002
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selection between the two groups.
Discussion
Our study explored the forces shaping the evolutionary history of
class II aPMV-1 using available full genome sequences. We
demonstrated that genotype affiliations based on individual genes
and concatenated full length genomes of class II aPMV-1 were not
consistent. This may account for discrepancies reported for
genotype groupings that are based on partial or complete sequences
of a single gene [13,18,43]. Topological incongruence among the
gene trees reflects different evolutionary histories of each gene [44];
recombination is the most plausible explanation for this. The role of
recombination in the evolution of aPMV-1, and negative sense
RNA viruses in general, has been debated. For example, Sakaguchi
et al. [30] and Toyoda et al, [31] reported consistent topological
placement of different NDV strains in both F and HN gene trees.
Seal et al. [45] also reported that there was no evidence of
recombination among NDV M gene sequences. Although recom-
bination is more common in positive-sense RNA viruses and can be
explained by several genetic mechanisms [46], there is increasing
evidence of homologous recombination in several non-segmented
negative-sense RNA viruses [32,47,48,49,50]. Our approach differs
from those used in previous studies of aPMV-1 evolution because
we evaluated full genome sequences and tested individual
recombinant regions with phylogeny-based incongruence tests.
Thus, we show that all class II aPMV-1 genes have evidence of
recombination breakpoints, that multiple recombination events are
discernable in some isolates, and that both intragenic and intergenic
recombinationeventsareevident.We considered thepossibilitythat
the recombinants detected in our analysis were the result of
laboratory artifacts, as has been previously suggested [32,51].
Laboratory contamination is of concern because vaccine derived
strains contributed the majority of the recombinant regions and
these strains might have been present in laboratories sequencing
field aPMV-1 isolates. The presence of unique nucleotide
substitutions in the recombinant regions compared to the
comparable region of the predicted parental genotypes suggests
that these regions did not arise due to contamination with vaccine
strains deposited in the sequence databases.
Our identification of recombinants derived from vaccine strains
indicates that birds can be simultaneously infected with the live
virus vaccine and other circulating aPMV-1 genotypes. Indeed
vaccination is reported to protect poultry from disease but not
always from infection with other strains [7,8,9]. Suboptimal
vaccination strategies could also lead to birds becoming infected
with both a vaccine strain and circulating genotype, which can
alter viral virulence [16]. This is an important issue for poultry
management. Lack of vaccine efficacy has not frequently been
reported in the United States but other countries such as Nigeria
[52], Korea [53], Taiwan [54], and China [34,55] have
experienced vaccine failures. Recombination between wild type
virus and vaccine strains is not unique to aPMV-1; vaccine
recombinants of bovine viral diarrhea virus (associated with fatal
mucosal disease) [35], poliovirus (associated with paralytic
poliomyelitis) [36,37]; and infectious bursal disease virus [38]
have all been reported. This raises concerns that modified live
virus vaccines, although efficacious, may facilitate emergences of
new strains with unpredictable phenotypes through recombination
with circulating viruses.
The evolutionary rates presented here for class II aPMV-1 are
compatible with the rates estimated for other RNA viruses (e.g.
[56,57,58]), suggesting that class II aPMV-1 is also a rapidly
evolving RNA virus. The relatively lower evolutionary rate for
genotype II is consistent with the rate that was previously reported
for avirulent NDV [33]. The larger effective population size,
which counters the impact of genetic drift, is a possible explanation
for lower evolutionary rates of genotype II. Based on these rate
estimates, the TMRCA of this virus is estimated to be between
1868–1891, which is earlier than the first recorded outbreak of ND
in Indonesia and England in the 1920’s [2]. However, our data are
in line with observations by Macpherson [59], who suggested that
an outbreak of disease in domestic birds that occurred in
Northwest Scotland from 1897–1898 was due to NDV.
The demographic history of class II aPMV-1 determined by
Bayesian skyline plots indicated that there was an abrupt decline in
population size during 1997–98. Although the factors responsible
for such an abrupt decline in class II aPMV-1 are not known, the
impact of a severe El-Nino event during that time frame [60] or
the slaughter of millions of domestic fowl during the first outbreak
of H5N1 avian influenza virus in 1997 [61,62] could be possible
explanations.
In contrast to the other genotypes, genotype II was not
impacted by factors causing population decline in the late 1990s.
We expected that vaccination, which started worldwide in the
Table 3. Site-specific selection analysis for each coding gene of vaccine- and nonvaccine-related groups.
Gene Total number of codons Global dN/dS
*(codon position
")
Vaccine-related group Nonvaccine-related group
NP 489 0.119 (None) 0.100 (467
1)
P 395 0.266 (None) 0.336 (87
1,9 0
1, 380
1)
M 364 0.176 (None) 0.123 (None)
F 553 0.166 (115
¥) 0.139 (28
{)
HN 616 0.166 (266
1,4 9 5
{,5 2 2
{) 0.171 (508
1)
L 2204 0.088 (None) 0.094 (None)
Strains used for selection analyses in both groups are mentioned in Table S1.
"Position of codon under positive selection with p,0.05.
¥Significant in PAML analysis.
1Significant in FEL analysis.
{Significant in both FEL and PAML analysis.
*Rate of Non-synonymous (dN) to Synonymous (dS) substitution.
doi:10.1371/journal.ppat.1000872.t003
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thus causing a bottleneck for this genotype. However, the impact
of NDV vaccination is not seen in the BSP. It is possible that the
data available in GenBank is insufficient to capture the population
history of this genotype. However, a plausible explanation for the
absence of a population bottleneck could be that genotype II NDV
is maintained as an asymptomatic infection because it is
continually introduced to susceptible populations as a modified
live vaccine. Vaccination effectively prevents birds from develop-
ing disease when exposed to a virulent strain, but does not prevent
shedding [7]. Thus, the number of available susceptible hosts may
not dictate genotype II population demographics.
Although overall all genes of class II aPMV-1 are evolving
under purifying selection consistent with other paramyxoviruses
[33,56,63], distinctive profiles of positively selected codons were
shown in both vaccine- and nonvaccine-related groups. Notably, P
gene had the highest dN/dS ratio of any gene and had three sites
predicted to be under selection in the nonvaccine-related group;
there were no sites under selection in P gene in the vaccine related
group. In contrast, HN had three sites predicted to be under
selection in the vaccine related group. Of interest, codon 115 in
the F cleavage domain is positively selected only in vaccine-related
groups. Previous studies have reported that a single amino acid
substitution at codon-115, which falls within the F0 cleavage site,
resulted in a dramatic change from an avirulent infection to highly
virulent NDV [64,65,66]. In contrast to the results reported in the
present study, Miller et al [33] did not identify codon115 in F gene
under positive selection. This is likely due to differences in the data
sets because factors such as sequence length, sequence divergence,
and the number of sequences can determine the ability to detect
positively selected sites [67]. Thus, the vaccine-related genotypes I
and II maintain a phenotypic mixture of strains with different
infection and pathogenic potential and selection profiles.
Materials and Methods
Sequences data collection and phylogenetic analyses
A total of 54 complete genome sequences of class II aPMV-1
representing different avian hosts, geographic regions, year of
isolation, and genotypes (based on previous published phylogenetic
grouping) were retrieved from GenBank. The coding genome
sequences were aligned using MEGA version 4 [68]. Six separate
coding gene sequences datasets (for NP, P, M, F, HN and L genes)
were generated (see Table S1) and a concatenated genome
sequence from these six coding gene sequences was generated
using Mesquite version 1.12 (http://mesquiteproject.org). Appro-
priate model of nucleotide substitution for each dataset was
selected by the hierarchical likelihood ratio test implemented in
Modeltest version 3.7 [69]. Maximum likelihood (ML) trees were
reconstructed for all data sets using the heuristic search option,
implementing stepwise addition with 100 random addition
replicates and tree bisection-reconnection branch swapping in
PAUP* version 4beta10 [70] and PHYML 3.412 [71] with 100
non-parametric bootstrapping replicates analyses. The inferred
trees were visualized with FigTree version 1.12 (http://tree.bio.ed.
ac.uk/software/figtree/) and the congruency of topology place-
ment of class II aPMV-1 genotypes based on each gene and
concatenated genome was tested using the Shimadoira, Hasegawa
(SH) test [72] implemented in PAUP. The concatenated tree was
constrained and tested versus other gene trees.
Putative recombination detection
The recombination predictions of the concatenated genome
sequences were conducted with a suite of programs within the
RDP3 package [39,40]. The individual programs RDP [39],
GENECONV [73], Bootscan [40], Maximum Chi [74], Chimae-
ra [75], SiScan [76] and 3Seq [77], were implemented for the
analysis. Since no single program provided optimal performance
under all conditions, any event supported by five or more methods
with p-values #10
25 was the criteria used for positive recombi-
nation breakpoints identification. The breakpoint position and the
putative parental sequences were also determined.
Estimation of evolutionary rates and past population
dynamics
Twenty six full length genome sequences for which year of
isolationwasavailablewere used toinferevolutionaryrate anddates
using BEAST version 1.4.8 [41]. Demographic history of a
population/species using multi-locus data, even from a small
number of individuals, can precisely recover past bottlenecks in
population size that cannot be characterized by analysis of a single
locus [78]. Given this fact, estimates based on the whole genome
sequence data are expected to be more reliable. To determine the
population history of individual genotypes, 149 complete F gene
sequences, which had dates of collection, were retrieved from
GenBank. Phylogenetic analyses were done as described previously
(Table S2). From the ML tree, a total of 97 isolates from genotype I,
II, VI, and VII were selected to infer evolutionary rates and
population dynamics. These included all available dated full length
sequences from Genotypes I (24 sequences), II (28 sequences), and
VI (23 sequences). The majority (95%) of genotype VII sequences
were of Chinese origin. Thus, we included the seven non-Chinese
sequences and picked an additional 15 sequences based on
phylogenetic diversity to represent genotype VII in our analyses.
The evolutionary rate (nucleotide substitutions per site per year) of
each gene and concatenated genome was estimated using the
Bayesian Markov chain Monte Carlo analyses (independent
assumption of codivergence). Substitution models of both HKY +
G4 and GTR + G6 with estimated base frequencies, gamma and
invariable site portion were used, with uncertainty in the data
reflected in the 95% high-probability density (HPD) intervals. Strict
clock and uncorrelated exponential (UCED) relaxed clock models
were attempted independently, and the best-fit clock model was
determined to be UCED based on the Bayes Factor calculated from
their posterior distributions (Table S3). The Coalescent Bayesian
skyline plot (BSP) was used to infer the past population dynamics.
The BSP was constructed using the growth rate and demographic
parameters from the selected best-fit models. Bayesian Markov
Chain Monte Carlo (BMCMC) analyses were run for 5–10610
8
generations depending on each dataset. Convergence of trees was
checked using Tracer v1.4.1 (http://beast.bio.ed.ac.uk/Tracer).
Selection analysis
Selection analyses were done based on datasets without putative
recombinant sequences because recombination can result in falsely
identifying positive selection [79]. The datasets were split into a
vaccine-related group, which included strains from genotypes I
and II, and nonvaccine-related group, which included strains from
genotypes III, IV, V, VI, VII (see Table S2). Positively selected
codons were detected using Fixed- Effect Likelihood (FEL) via the
Datamonkey website (http://www.datamonkey.org/) and ML
approach implemented in CODEML (PAML package version
3.15)[80]. For FEL analysis, p-values less than 0.05 were used to
support positive selection. For PAML analysis, the likelihood ratio
test was used to compare M1a, M7 and M8a models that assume
no positive selection (v,1) with those M2a and M8 models that
assume positive selection (v.1)[81].
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